Thomas Reiser/LinkedIn
Oct 18, 2025, 05:21
Thomas Reiser: ISTH Guidelines and Guidance Committee Invites Public Comments on the Guidance Manuscript
Thomas Reiser, Executive Director of the International Society on Thrombosis and Haemostasis (ISTH), shared on LinkedIn:
“Your expertise is requested!
The International Society on Thrombosis and Haemostasis (ISTH) Guidelines & Guidance Committee invites public comments on the guidance manuscript, “Development of New Antithrombotic Drugs for Children (Part 1): Guidance from the SSC Subcommittee on Pediatrics & Neonatal Thrombosis and Hemostasis and the Pedi-ATLAS Group”
Deadline: Oct. 30″
Register here.
Stay informed with Hemostasis Today.
-
Jan 27, 2026, 14:06Dmitrii V Kalinin Shares A PhD Opportunity: Hardiman Scholarship
-
Jan 27, 2026, 13:48Filippo Cademartiri: 3 Biomarkers Are Better Than 1: Refining ASCVD Risk in MESA
-
Jan 27, 2026, 12:27Martin Haluzík on Residual Cardiovascular Risk in Coronary Artery Disease
-
Jan 27, 2026, 12:18Stuart Phillips: Strong Bodies Are Good, Informed Bodies Are Better!
-
Jan 27, 2026, 12:07Daniel Torrent: This Should Be An Ice Cold Take… But Veins Aren’t Arteries
-
Jan 27, 2026, 09:17Paolo Zamboni on CCSVI Associated to Multiple Sclerosis
-
Jan 27, 2026, 09:02Rowan Paul: Platelet Dose Determines Success in PRP Therapy
-
Jan 27, 2026, 08:48Uriel Suárez: Hemi‐Orolingual Angioedema in a Patient With VEXAS Syndrome
-
Jan 27, 2026, 08:23Rossella Crescitelli on Platelets’ and PEVs’ Association with Lung Cancer Metastases